Related references
Note: Only part of the references are listed.Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer
Esther C. de Haas et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors:: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T9313P)
S. Culine et al.
ANNALS OF ONCOLOGY (2007)
Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patients
J Nuver et al.
PHARMACOGENETICS AND GENOMICS (2005)
Bleomycin lung toxicity: who are the patients with increased risk?
E Azambuja et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2005)
Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours
JM O'Sullivan et al.
ANNALS OF ONCOLOGY (2003)
High prevalence of the IVS14+1G>A mutation in the dihydropyrimidine dehydrogenase gene of patients with severe 5-fluorouracil-associated toxicity
ABP van Kuilenburg et al.
PHARMACOGENETICS (2002)
Share Paper
